PRLD
Prelude Therapeutics Inc
NASDAQ · Healthcare · Biotechnology · US
$3.88
−5.37%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 17.13x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.32x
- Price / sales
- 13.81x
- Price / cash flow
- -9.31x
Enterprise value
- Enterprise value
- $175.5M
- EV / sales
- 7.83x
- EV / EBITDA
- -2.98x
- EV / EBIT
- -2.60x
- Market cap
- $309.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026